• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于XGBoost/贝叶斯方法和集成模型方法的机器学习驱动的mRNA-脂质纳米颗粒疫苗质量优化

Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches.

作者信息

Maharjan Ravi, Kim Ki Hyun, Lee Kyeong, Han Hyo-Kyung, Jeong Seong Hoon

机构信息

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi, 10326, Republic of Korea.

College of Pharmacy, Mokpo National University, Jeonnam, 58554, Republic of Korea.

出版信息

J Pharm Anal. 2024 Nov;14(11):100996. doi: 10.1016/j.jpha.2024.100996. Epub 2024 May 8.

DOI:10.1016/j.jpha.2024.100996
PMID:39759971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11696778/
Abstract

To enhance the efficiency of vaccine manufacturing, this study focuses on optimizing the microfluidic conditions and lipid mix ratios of messenger RNA-lipid nanoparticles (mRNA-LNP). Different mRNA-LNP formulations ( = 24) were developed using an I-optimal design, where machine learning tools (XGBoost/Bayesian optimization and self-validated ensemble (SVEM)) were used to optimize the process and predict lipid mix ratio. The investigation included material attributes, their respective ratios, and process attributes. The critical responses like particle size (PS), polydispersity index (PDI), Zeta potential, pKa, heat trend cycle, encapsulation efficiency (EE), recovery ratio, and encapsulated mRNA were evaluated. Overall prediction of SVEM (>97%) was comparably better than that of XGBoost/Bayesian optimization (>94%). Moreover, in actual experimental outcomes, SVEM prediction is close to the actual data as confirmed by the experimental PS (94-96 nm) is close to the predicted one (95-97 nm). The other parameters including PDI and EE were also close to the actual experimental data.

摘要

为提高疫苗生产效率,本研究聚焦于优化信使核糖核酸-脂质纳米颗粒(mRNA-LNP)的微流控条件和脂质混合比例。使用I-最优设计开发了不同的mRNA-LNP配方(n = 24),其中利用机器学习工具(XGBoost/贝叶斯优化和自验证集成(SVEM))来优化工艺并预测脂质混合比例。该研究涵盖材料属性、它们各自的比例以及工艺属性。对诸如粒径(PS)、多分散指数(PDI)、zeta电位、pKa、热趋势循环、包封效率(EE)、回收率和包封的mRNA等关键响应进行了评估。SVEM的总体预测(>97%)比XGBoost/贝叶斯优化(>94%)要好。此外,在实际实验结果中,SVEM预测与实际数据接近,如实验测得的PS(94 - 96纳米)接近预测值(95 - 97纳米)所证实。包括PDI和EE在内的其他参数也与实际实验数据接近。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/9f7156050e19/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/cfa878103ab9/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/b800223066ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/ca55f917f488/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/a38a6a705ec7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/b587c8021383/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/0e529fb61d0e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/40409e5c8838/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/138a28907d81/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/a72f453cb2f1/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/afce048277af/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/9f7156050e19/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/cfa878103ab9/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/b800223066ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/ca55f917f488/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/a38a6a705ec7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/b587c8021383/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/0e529fb61d0e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/40409e5c8838/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/138a28907d81/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/a72f453cb2f1/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/afce048277af/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee7/11696778/9f7156050e19/gr10.jpg

相似文献

1
Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches.基于XGBoost/贝叶斯方法和集成模型方法的机器学习驱动的mRNA-脂质纳米颗粒疫苗质量优化
J Pharm Anal. 2024 Nov;14(11):100996. doi: 10.1016/j.jpha.2024.100996. Epub 2024 May 8.
2
Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach.基于脂质纳米颗粒的 mRNA 疫苗生物工艺的比较研究与机器学习和组合人工神经网络-实验设计方法。
Int J Pharm. 2023 Jun 10;640:123012. doi: 10.1016/j.ijpharm.2023.123012. Epub 2023 May 2.
3
Understanding the Manufacturing Process of Lipid Nanoparticles for mRNA Delivery Using Machine Learning.利用机器学习理解 mRNA 递释用脂质纳米粒的制造工艺。
Chem Pharm Bull (Tokyo). 2024;72(6):529-539. doi: 10.1248/cpb.c24-00089.
4
A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM).使用设计的混合过程实验和自验证集成模型(SVEM)优化脂质纳米粒子(LNP)配方的工作流程。
J Vis Exp. 2023 Aug 18(198). doi: 10.3791/65200.
5
Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.通过机器学习算法预测用于mRNA疫苗的脂质纳米颗粒。
Acta Pharm Sin B. 2022 Jun;12(6):2950-2962. doi: 10.1016/j.apsb.2021.11.021. Epub 2021 Dec 2.
6
A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient.仔细观察脂质纳米颗粒的特征:分析用于包裹 RNA 货物大小梯度的基准制剂。
Sci Rep. 2024 Jan 29;14(1):2403. doi: 10.1038/s41598-024-52685-1.
7
Process Optimization of Charge-Reversible Lipid Nanoparticles for Cytosolic Protein Delivery Using the Design-of-Experiment Approach.采用实验设计方法对用于胞质蛋白递送的电荷可逆脂质纳米颗粒进行工艺优化。
Biol Pharm Bull. 2025;48(3):286-297. doi: 10.1248/bpb.b24-00722.
8
Optimizing nanoliposomal formulations: Assessing factors affecting entrapment efficiency of curcumin-loaded liposomes using machine learning.优化纳米脂质体制剂:使用机器学习评估影响载姜黄素脂质体包封效率的因素。
Int J Pharm. 2023 Nov 5;646:123414. doi: 10.1016/j.ijpharm.2023.123414. Epub 2023 Sep 13.
9
Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery.实验设计(DoE)作为质量源于设计(QbD)工具,用于优化用于脑内递药的脂质纳米粒的制剂。
Expert Opin Drug Deliv. 2023 Jul-Dec;20(12):1731-1748. doi: 10.1080/17425247.2023.2274902. Epub 2023 Dec 29.
10
Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.载有地西泮的纳米结构脂质载体(NLC)经鼻脑递药的质量源于设计(QbD)优化:表面电荷对人神经细胞的毒理学效应。
Int J Pharm. 2021 Sep 25;607:120933. doi: 10.1016/j.ijpharm.2021.120933. Epub 2021 Jul 27.

引用本文的文献

1
Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines.基于人工智能的策略用于靶向递送和增强基于RNA的脂质纳米颗粒癌症疫苗的稳定性
Pharmaceutics. 2025 Jul 30;17(8):992. doi: 10.3390/pharmaceutics17080992.
2
Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy.用于体外和体内基因治疗的微流控平台
Biosensors (Basel). 2025 Aug 4;15(8):504. doi: 10.3390/bios15080504.
3
Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity.

本文引用的文献

1
AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery.AGILE 平台:一种基于深度学习的方法,可加速用于 mRNA 递送的 LNPs 开发。
Nat Commun. 2024 Jul 26;15(1):6305. doi: 10.1038/s41467-024-50619-z.
2
A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM).使用设计的混合过程实验和自验证集成模型(SVEM)优化脂质纳米粒子(LNP)配方的工作流程。
J Vis Exp. 2023 Aug 18(198). doi: 10.3791/65200.
3
Machine-learning-based predictions of imprinting quality using ensemble and non-linear regression algorithms.
下一代疫苗平台:整合合成生物学、纳米技术和系统免疫学以提高免疫原性
Vaccines (Basel). 2025 May 30;13(6):588. doi: 10.3390/vaccines13060588.
4
Bayesian optimization and machine learning for vaccine formulation development.用于疫苗配方开发的贝叶斯优化与机器学习
PLoS One. 2025 Jun 11;20(6):e0324205. doi: 10.1371/journal.pone.0324205. eCollection 2025.
5
Development and validation of a prediction model for myelosuppression in lung cancer patients after platinum-based doublet chemotherapy: a multifactorial analysis approach.基于铂类双药化疗的肺癌患者骨髓抑制预测模型的开发与验证:多因素分析方法
Am J Cancer Res. 2025 Feb 15;15(2):470-486. doi: 10.62347/TFUC2568. eCollection 2025.
6
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.用于癌症免疫治疗的mRNA疫苗设计中的计算生物学与人工智能
Front Cell Infect Microbiol. 2025 Jan 20;14:1501010. doi: 10.3389/fcimb.2024.1501010. eCollection 2024.
使用集成和非线性回归算法基于机器学习对印记质量进行预测。
Sci Rep. 2023 Jul 26;13(1):12111. doi: 10.1038/s41598-023-39374-1.
4
Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery.基于设计实验(DoE)的方法对脂质纳米颗粒组成对核酸递送影响的综合建模评估。
Biomaterials. 2023 Aug;299:122158. doi: 10.1016/j.biomaterials.2023.122158. Epub 2023 May 15.
5
Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach.基于脂质纳米颗粒的 mRNA 疫苗生物工艺的比较研究与机器学习和组合人工神经网络-实验设计方法。
Int J Pharm. 2023 Jun 10;640:123012. doi: 10.1016/j.ijpharm.2023.123012. Epub 2023 May 2.
6
Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids.mRNA LNP 制剂的成功批和连续冷冻干燥取决于冷冻保护剂和可离子化脂质。
Biomater Sci. 2023 Jun 13;11(12):4327-4334. doi: 10.1039/d2bm02031a.
7
Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?人工智能能否彻底改变用于基因治疗和mRNA疫苗的纳米载体的研发?
Nano Today. 2022 Dec;47. doi: 10.1016/j.nantod.2022.101665. Epub 2022 Nov 7.
8
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis.核酸纳米组装增强的RNA治疗与诊断
Acta Pharm Sin B. 2023 Mar;13(3):916-941. doi: 10.1016/j.apsb.2022.10.019. Epub 2022 Oct 27.
9
Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice.脂质组合物中胆固醇含量对 mRNA-LNPs 经局部给药后在注射部位和肝脏中蛋白表达的影响。
J Pharm Sci. 2023 May;112(5):1401-1410. doi: 10.1016/j.xphs.2022.12.026. Epub 2022 Dec 31.
10
Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer.脂质微粒在递送 mRNA 和预防癌症方面与脂质纳米颗粒具有相似的疗效。
Pharm Res. 2023 Jan;40(1):265-279. doi: 10.1007/s11095-022-03445-1. Epub 2022 Nov 30.